$AMGN Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $6.45 up 14.36% YoY
• Reported revenue of $10.37B up 8.45% YoY
• Amgen expects full-year 2026 total revenues in the range of $38.9B to $39.7B, GAAP EPS of $18.34 to $19.28, and non-GAAP EPS of $22.90 to $23.70.